Polymeric micelles for the delivery of polyene antibiotics

ACS Symposium Series

Volumn 923, Issue , 2006, Pages 14-26

  Vakil, Ronak ^a   Kuldipkumar, Anuj ^a   Andes, David ^b   Tan, Yvonne ^c   Kwon, Glen S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36949034517     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-2006-0923.ch002     Document Type: Conference Paper

References (21)

1. Kataoka, K.; Kwon, G. S.; Yokoyama, M.; Okano, T.; Sakurai, Y. Block copolymer micelles as vehicles for drug delivery. J. Controlled Release 1993, 24, 119.
2. Torchilin, V. P. Structure and design of polymeric surfactant-based drug delivery systems. J. Controlled Release 2001, 73, 137.
3. Kwon, G. S. Polymeric micelles for delivery of poorly water-soluble compounds. Crit. Rev. Ther. Drug Carrier Syst. 2003, 20, 357.
4. Jonkman-de Vries, J. D.; Flora, K. P.; Bult, A.; Beijnen, J. H. Pharmaceutical development of (investigational) anticancer agents for parenteral use. A review. Drug Dev. Ind. Pharm. 1996, 22, 475.
5. Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 2001, 37, 1590.
6. Torchilin, V. P.; Lukyanov, A. N.; Gao, Z.; Papahadjopoulos-Sternberg, B. Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proceed. Natl. Acad. Sci. USA 2003, 100, 6039.
7. Liu, J.; Xiao, Y.; Allen, C. J. Polymer-drug compatibility: A guide to the development of delivery systems for the anticancer agent, ellipticine. J. Pharm. Sci. 2004, 93, 132.
8. Zhang, L.; Eisenberg, A. Multiple morphologies of "crew-cut" aggregates of polystyrene-b-poly(acrylic acid) block copolymers. Science 1995, 268, 1728.
9. Discher, B.; Won, Y.-Y.; Ege, D. S.; Lee, J. C.-M.; Bates, F. S.; Discher, D. E.; Hammer, D.A. Polymersomes: Tough vesicles made from diblock copolymers. Science 1999, 284, 1143.
10. Bae, Y.; Fukushima, S.; Harada, A.; Kataoka, K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. 2003, 42, 4640.
11. Nishiyama, N.; Okazaki, S.; Cabral, H.; Miyamoto, M.; Kato, Y.; Sugiyama, Y.; Nishio, K.; Matsumura, Y.; Kataoka, K. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 2003, 63, 8977.
12. Duncan, R. The dawning era of polymer therapeutics. Nature Rev. Drug Discov. 2003, 2, 347.
13. Brajtburg, J.; Bolard, J. Carrier effects on biological activity of amphotericin B. Clin. Microbiol. Rev. 1996, 9, 512.
14. Fridkin, S. K.; Jarvis, W. R. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 1996, 9, 499.
15. Adams, M. L.; Andes, D. R.; Kwon, G. S. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity. Biomacromolecules 2003, 4, 750.
16. Gruda, I.; Dussault, N. Effect of the aggregation state of amphotericin B on its interaction with ergosterol. Biochem. Cell Biol. 1988, 66, 177.
17. Croy, S. R.; Kwon, G. S. The effects of Pluronic block copolymers on the aggregation state of nystatin. J. Controlled Release 2004, 95, 161.
18. Barwicz, J.; Christian, S.; Gruda, I. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob. Agents Chemother. 1992, 36, 2310.
19. Tasset, C.; Preat, V.; Roland, M. The influence of Myrj 59 on the solubility, toxicity and activity of amphotericin B. J. Pharm. Pharmacol. 1991, 43, 297.
20. Lavasanifar, A.; Samuel, J.; Sattari, S.; Kwon, G. S. Block copolymer micelles for the encapsulation and delivery of amphotericin B. Pharm. Res. 2002, 19, 418.
21. Adams, M. L.; Kwon, G. S. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by polyethylene oxide)-block-poly(N- hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length. J. Controlled Release 2003, 87, 23.